Approval · Notice of Compliance 37658 · 2026
BMD SOLUBLE: Notice of Compliance 37658
Issued June 4, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37658
- Date
- June 4, 2026
- Company
- Phibro Animal Health CorporationTeaneck, New Jersey, United States
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative – Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BMD SOLUBLE | 02328135 | Dormant |
Medicinal ingredients
- BACITRACIN METHYLENE DISALICYLATE 440 MG per G